Key Drivers
- Cash generation
- Heavy leverage
- Thin coverage
AIAI Summary
HLF's improving sales and Bioniq-driven stabilization are encouraging, but the real investment call is whether that growth can outrun a fragile, highly levered capital structure—until margins, earnings, and debt reduction improve materially, the stock remains a balance-sheet risk rather than a true re-rating story.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash generation
- •Heavy leverage
- •Thin coverage
HLF remains cash-generative and cheap on earnings, but heavy debt, negative equity, and sub-1.0x interest coverage make the balance sheet the main risk.
Price Behavior
Key Price Behavior Insights:
- •Support holding
- •Overhead resistance
- •Volatility elevated
HLF has been mostly range-bound over the last month with a slight upward bias, as buyers held $11.50-$11.70 support and the stock reclaimed $11.70-$11.90, but it still needs a decisive break above $12.73-$12.80 to confirm stronger momentum.
Failed at $12.80 and dropped quickly to $11.52, signaling sharp volatility
Sentiment & News
Key News Insights:
- •Sales Momentum
- •Earnings Miss
- •CFO Transition
Herbalife delivered 5.4% Q2 sales growth and a fourth straight quarter of revenue gains, but earnings missed expectations as it announced a CFO transition and continued expanding Bioniq.
The news is modestly positive for top-line momentum but remains only neutral overall until Herbalife shows stronger profit conversion
Similar Companies in Consumer Defensive
Other companies in the same sector with AI ratings